Darolutamide is an antiandrogen active pharmaceutical ingredient used in the manufacture of medications for prostate cancer. It is typically administered twice daily with food as part of hormonal therapy.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Darolutamide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ketodarolutamide
pharmaceutical raw material
Rifalazil
pharmaceutical raw material
Dapoxetine hydrochloride
pharmaceutical raw material
(2R,3ar,6ar)-1-((2S)-2-(((1S)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)propanoyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid
pharmaceutical raw material
Selank
pharmaceutical raw material
The international HS code for Darolutamide (CAS 1297538-32-9) is 2933.19.
2933.19
2933 19 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)pyrazol-1-yl]propan-2-yl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide
BLIJXOOIHRSQRB-PXYINDEMSA-N
C[C@@H](CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O
Sourcing Darolutamide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.